Skip to main content

SUBJ: Enjoy your coffee

SUBtitle: Yogurt and SAMe for microbiome maintenance

See past newsletters here

SHORT NOTES: Drinking 2+ cups of coffee a day benefits your liver and reduces dementia risk; Keeping a healthy microbiome boosts your immune system and reduces hypertension – eat yogurt and fast periodically for 12+ hours; There is an interplay between epigenetics and healthy aging (SAMe is vital for epigenetic marking); Brain stimulation approved for major depression; Success in trials of multiple myeloma treatment; While GDF11 has potential anti-aging benefits, it is several years away from human application.

LONG NOTES

Web MD on Coffee – If you can’t make it through the day without it, you’ll be glad to hear that it may have some benefits for your liver. Studies show that drinking two to three cups a day can protect your liver from damage caused by too much alcohol or an unhealthy diet. Some research suggests it may lower your risk of liver cancer. [also reduces risk for dementia and Alzheimers]

The Relationship Between the Gut Microbiome and Declining Immune Function in Aging

Changes in the Gut Microbiome Contribute to Hypertension, and are Diminished by Fasting

For microbiome health, get kefir or yogurt every day.

This open access review  will explore the interplay between epigenetics and aging, and how epigenetic reprogramming can be harnessed for age reversal.  In vivo partial reprogramming holds great promise as a possible therapy, but several limitations remain. Rejuvenation by reprogramming is a young but rapidly expanding subfield in the biology of aging. A ride through the epigenetic landscape: aging reversal by reprogramming: Abstract Aging has become one of the fastest-growing research topics in biology. However, exactly how the aging process occurs remains unknown.  Epigenetics plays a significant role, and several epigenetic interventions can modulate lifespan. (SAMe is essential for proper epigenetic marking – )

Brain stimulation approved for major depression.

Success in trials of multiple myeloma treatment.

While GDF11 has potential anti-aging benefits, it is several years away from human application.